US FDA Certificate
Business Services · India · 1-10 Employees
View Company Info for Free
Overview
Headquarters
F/7 Shukun Plz L. G. Cor, S A Mills, Guj...Phone Number
+91 9426756555Website
www.usfda.netRevenue
<$5 MillionIndustry
About US FDA Certificate
US FDA Certificate Org Chart
Is US FDA Certificate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at US FDA Certificate
Check if US FDA Certificate has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on US FDA Certificate recently announced quarterly report
Check out if US FDA Certificate is spiking on competitors!
Funding: Get notified immidiatlly once US FDA Certificate has new funding data
Product Launch: Get notified when US FDA Certificate launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if US FDA Certificate had a recent Job posting/layoffs
US FDA Certificate, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at US FDA Certificate
Find 3 more new buyers
Company Profile Activity
Activity Insights
US FDA Certificate is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
US FDA Certificate is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about US FDA Certificate.
US FDA Certificate Tech Stack
US FDA Certificate News & Media
GNTbm's self-developed anti-cancer new drug GNTbm-38 has obtained IND approval from the U.S. FDA for Phase I clinical trials
TAIPEI, March 5, 2026 /PRNewswire/ -- Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer immunotherapy, has received approval from the U.S....XellSmart Receives Fourth Consecutive US FDA & China NMPA IND Clearance for MSA-P iPSC-derived Cell Therapy
SUZHOU, China, March 2, 2026 /PRNewswire/ -- In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its independently developed, off-the-shelf, allogeneic, universal, iPSC-derived, subtype-specific neuron progenitor cell therapy targeting Multiple System Atrophy- Parkinsonian Type (MSA-P). This joins the previous three consecutive FDA-NMPA registrational triaUS FDA launches program to boost domestic drug manufacturing
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S.Inovio announces U.S. FDA accepted BLA for INO-3107
INOVIO (INO) announced that the U.S. Food and Drug Administration, FDA, accepted the company’s Biologics License Application, BLA, for INO-3107 for review as a potential treatment for adults with RRP. The review classification designated by FDA is Standard. The FDA assigned INO-3107 a Prescription Drug User Fee Act, PDUFA, review goal date of October 30, 2026, which is the date by which it intends to take action on the application. The FDA has indicated that
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding US FDA Certificate
Samrat Associates is a consultancy firm based in Ahmedabad, India, specializing in US FDA certification services for various industries including food, pharmaceuticals, and medical devices. They provide comprehensive support for companies seeking to navigate the complexities of FDA regulations, ensuring compliance for successful market entry into t... Read More